Accuracy of a Rapid and Non-Invasive Method for the Assessment of Small Fiber Neuropathy Based on Measurement of Electrochemical Skin Conductances by Lyse Bordier et al.
February 2016 | Volume 7 | Article 181
Data RepoRt
published: 29 February 2016
doi: 10.3389/fendo.2016.00018
Frontiers in Endocrinology | www.frontiersin.org
Edited by: 
Gaetano Santulli, 
Columbia University, USA
Reviewed by: 
Hiroki Mizukami, 
Hirosaki University Graduate School 
of Medicine, Japan 
Grazia Devigili, 
University Hospital of Udine, Italy
*Correspondence:
Marie-Laure Névoret  
marie-laure.nevoret@impeto-medical.
com
Specialty section: 
This article was submitted to 
Diabetes, a section of the journal 
Frontiers in Endocrinology
Received: 26 November 2015
Accepted: 15 February 2016
Published: 29 February 2016
Citation: 
Bordier L, Dolz M, Monteiro L, 
Névoret M-L, Calvet J-H and 
Bauduceau B (2016) Accuracy of a 
Rapid and Non-Invasive Method for 
the Assessment of Small Fiber 
Neuropathy Based on Measurement 
of Electrochemical Skin 
Conductances. 
Front. Endocrinol. 7:18. 
doi: 10.3389/fendo.2016.00018
accuracy of a Rapid and  
Non-Invasive Method for the 
assessment of Small Fiber 
Neuropathy Based on Measurement 
of electrochemical Skin 
Conductances
Lyse Bordier1 , Manuel Dolz1 , Linsay Monteiro2 , Marie-Laure Névoret2* , Jean-Henri Calvet2 
and Bernard Bauduceau1
1 Service d’Endocrinologie, Hôpital d’Instruction-des-Armées-Bégin, Saint-Mandé, France, 2 Impeto Medical, Paris, France
Keywords: small fiber neuropathy, accuracy, reproducibility, sudomotor function, sweat glands
INtRoDUCtIoN
Peripheral nerves (PN) consist of small and large fibers (1). The small fibers represent 80% of PN and 
are long, thin, with little or no myelin. They are, therefore, more fragile and the first to be damaged in 
many pathological processes (2–5). The current clinical diagnostic methods mainly assess large fibers 
(6). Similarly the gold standard neurophysiological tool, namely nerve conduction studies or NCS, is 
also limited to measuring large fiber function. These recommended methodologies, therefore, only 
examine 20% of PN, those that are largest and degenerate late or not at all in certain diseases.
Small fibers can be sensory or autonomic and there are several methods to assess small fiber 
function or structure (7). Laser-evoked potentials assess A-delta fiber function (sensory nerves) 
but these instruments are not widely available (8). Quantitative sensory testing (QST) measures 
sensitivity to cold, heat, and vibration (sensory small and large fibers) and is more widely available 
but time-consuming and subjective for routine clinical practice (9). Skin biopsies can assess small 
fiber structure but are relatively invasive (3 mm in diameter, 1 month for full healing) and, thus, are 
ill suited for longitudinal assessments (10).
Sudomotor function assessing small fibers of the sympathetic autonomic system can be evaluated 
by the quantitative sudomotor axon reflex test (QSART); though considered the reference method, 
QSART remains mostly limited to research centers due to the technical complexity and relative 
discomfort of the examination (11). Other sudomotor methodologies include the Neuropad, which 
is semi-quantitative and not highly sensitive (12), quantitative direct and indirect testing (QDIRT) 
and the dynamic sweat test (DST). QDIRT and DST both induce sweating with iontophoresis of 
acetylcholine or pilocarpine; they are relatively tedious and not particularly suited to the outpatient 
clinic and there are no data validating the diagnostic utility of these newer technologies (13, 14). 
Specific stains can be used to evaluate sweat gland nerve fiber density (SGNFD), but there is currently 
no standardized methodology or normative reference ranges for SGNFD (15).
The SUDOSCAN® device was developed to allow the quantitative measurement of sweat gland 
function using a simple and rapid process (16, 17). Results are immediately available and expressed 
as electrochemical skin conductances (ESCs). This technique has been compared to reference 
neurological tests, is not operator dependent, and could be used in the follow-up of patients and in 
multi-center studies (18–21).
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The aim of this study was to assess repeatability and repro-
ducibility of the method in healthy volunteers (HV) and diabetic 
patients with a range of glycemic control.
MetHoDS
The study was performed in Bégin Hospital, Saint-Mandé, France 
on 18 HVs and 14 patients with type 2 diabetes (PTD2). All par-
ticipants gave their written informed consent.
SUDOSCAN® (Impeto Medical, Paris, France) is a patented 
device designed to perform a quantitative evaluation of sweat 
gland function based on the electrochemical reaction between 
ions in sweat (mainly chlorides at the anode and protons at the 
cathode) and stainless-steel electrodes. The apparatus consists of 
two sets of electrodes in contact with the palms of the hands and 
soles of the feet, where sweat gland density is highest, connected 
to a computer for recording and data management purposes 
[see depiction in Ref. (21)]. To conduct the test, the individual 
is required to stand still for 2 min. During the test, 4 combina-
tions of 15 different low direct current (DC) incremental voltages 
≤4 V are applied and electrodes serve alternatively as anode or 
cathode. Neither special subject preparation nor specially trained 
medical personnel is required to complete the test. ESC in the 
hands and feet, i.e., the ratio between current generated and the 
constant DC stimulus, are displayed on a monitor immediately 
after the test.
The principle of the method, including an electrochemical 
skin model, has been partially published and establishes that the 
concentrations of the electro-active species (i.e., chlorides near 
the anode, protons near the cathode) and the electric potential 
are mostly constant inside the sweat gland (22). The measured 
ESC equals the electric permeability of the gland wall against the 
electro-active species. In the human skin, including hairless skin 
such as the palms of the hands and soles of the feet, the stratum 
corneum is electrically insulating against DC voltages under 10 V 
and only the appendageal pathways of the eccrine sweat glands 
are conductive (23). Thus, ESC depends neither on the thickness 
of the stratum corneum nor on the sweat composition or conduc-
tivity, hence favoring a good reproducibility.
Sweat glands are innervated by the sympathetic autonomic 
peripheral nervous system with 70% cholinergic-muscarinic 
pathway and 30% adrenergic pathway (24). The physiologi-
cal process of sweating starts with a “chemical” stimulus, for 
example, in the cholinergic pathway, the binding of acetylcholine 
to muscarinic neuroreceptors that will modulate ion channels, 
creating a flux of ions through the membrane polarizing the gland 
to voltages around 10 mV. In the ESC technology, measurement 
is based on an initial electrical stimulus: it directly polarizes the 
gland with voltages between 100 and 1000 mV. This induces ion 
fluxes across the gland wall, depending on the electrochemical 
gradient of the ions. Because the current applied is high compared 
to the physiological current involved in ion exchange, the test can 
be considered a “stress test” for sweat glands.
Two measurements on three different Sudoscan devices were 
performed under usual testing conditions on each HV and 
PTD2. Measurements were performed in the same order for all 
subjects: first measurement on devices 1, 2, and 3 and then second 
measurement on devices 3, 2, and 1. Electrodes were cleaned after 
each test and an interval of at least 5 min was observed between 
two successive measurements.
A blind analysis of the data was performed by an independent 
party.
Statistical analyses
Comparison of measures recorded at different times on the three 
different devices was performed according to the ISO 5725-2 
standard “Accuracy (trueness and precision) of measurement 
methods and results – Part 2: Basic method for the determination 
of repeatability and reproducibility of a standard measurement 
method” (25).
Results for quantitative variables are shown as means ± SD. 
The data management and statistical analysis were done using 
SAS version 9.4 and R version 3.2.1. Bland–Altman analysis was 
used to assess agreement and bias between two measurements 
performed on the same device. Intraclass correlation coefficient 
(ICC) was calculated with the mean values obtained on each 
device to compare reproducibility between the three devices.
ReSULtS
The databases for this Report have been deposited in a public 
repository (figshare). Access is provided using the following link: 
http://figshare.com/s/f7792f2093c411e5b7e706ec4bbcf141
 – Demographics.xlsx contains the demographic information of 
the healthy controls and diabetic patients, with each individual 
denoted as the letter “S” followed by an Arabic numeral;
 – Reproducibility_healthy controls.xlsx contains the Sudoscan 
ESCs recorded for each subject for the hands (first sheet) and 
the feet (second sheet). The repeatability and reproducibility 
analyses are compiled for the hands ESC on the third sheet 
and for the feet ESC on the fourth sheet.
 – Reproducibility_diabetic subjects.xlsx contains the Sudoscan 
ESCs recorded for each subject for the hands (first sheet) and 
the feet (second sheet). The repeatability and reproducibility 
analyses are compiled for the hands ESC on the third sheet 
and for the feet ESC on the fourth sheet.
Participants were recruited and tested in September–October 
2015. Demographic characteristics of the HV were mean age: 
37  ±  13  years, mean BMI: 26  ±  4, 72% males. Among the 
PDT2 patients, these were mean age: 62 ± 9 years, mean BMI: 
29 ± 5 kg/m2, 71% males, mean HbA1C: 7.0 ± 0.9%, and mean 
diabetes duration: 10.8  years (range 5.5–15.0). All PDT2 had 
documentation of vibration perception, 10-g monofilament 
testing and ankle reflexes: eight patients had all normal results, 
four had one abnormal clinical sign, and two had two or more 
abnormal results.
Mean ESCs for all the measurements performed were 
75.8 ± 7.3 μS in HV and 62.6 ± 10.4 μS in PDT2 for the hands 
and 75.4 ±  5.5 μS in HV and 69.2 ±  9.4 μS in PDT2 for the 
feet. For hands ESC, the mean repeatability SD was 3.1  μS 
(mean coefficient of variation was 4.2 ±  2.7%) and the mean 
reproducibility SD was 3.2 μS (mean coefficient of variation was 
FIGURe 1 | Correlation between two successive measurements 
performed with the same device [(a) healthy population and (B) 
patients with type 2 diabetes].
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4.3 ± 2.7%) in HV, while they were 4.3 μS (mean coefficient of 
variation was 7.1 ± 5.9%) and 4.5 μS (mean coefficient of vari-
ation was 7.4 ± 6.1%), respectively, in PT2D. For feet ESC, the 
mean repeatability SD was 2.1 μS (mean coefficient of variation 
was 2.8 ±  1.6%) and the mean reproducibility SD was 2.3 μS 
(mean coefficient of variation was 3.1 ± 1.5%) in HV, while they 
were 4.3 μS (mean coefficient of variation was 6.9 ± 6.3%) and 
4.3 μS (mean coefficient of variation was 6.9 ±  6.3%), respec-
tively, in PT2D.
Repeatability is illustrated in Figure  1; reproducibility is 
depicted in Figure 2 with mean ± SD of all the measurements 
performed on the three devices. ICC used to compare the three 
devices were 0.87 (0.74–0.94) and 0.85 (0.71–0.93) in HV and 
0.95 (0.89–0.98) and 0.88 (0.74–0.96) in PDT2 for feet and hands, 
respectively.
DISCUSSIoN
This comparison between tests performed twice on three differ-
ent devices demonstrates that for feet ESC the mean coefficient of 
variation for repeatability was 2.8 ± 1.6% in HV and 6.9 ± 6.3% 
in PDT2, while coefficient of variation for reproducibility were 
3.1 ± 1.5 and 6.9 ± 6.3%, respectively. Similar or slightly higher 
values were observed for hands ESC.
Coefficients of repeatability and reproducibility are important 
for a test method to be useful in the follow-up of patients or in 
multi-center studies; differences in test results over time can be 
expected to reflect a true physiological change rather than the 
margin of error of the test itself. ESC repeatability and repro-
ducibility were previously assessed in several studies but never 
according to an accepted international standard, i.e., six measure-
ments for each subject in the same study. This accuracy study was 
eminently feasible due to the test’s (i) rapidity and ease of use, (ii) 
good acceptance by the patients, and (iii) lack of susceptibility 
to habituation, unlike some sudomotor function tests (26). The 
more common methods used in the assessment of peripheral 
neuropathy would not have allowed for such complete accuracy 
testing.
The results obtained in this study are in accordance or even 
better than previously reported coefficients of variation for ESC 
measurements (18, 27). The higher variation observed for hands 
ESC compared to feet ESC mainly in HV remain acceptable for 
measurements performed according to usual practice. In fact, it 
is most likely explained by the difference in the contact of the 
hands on the electrodes: whereas the feet are aided by gravity 
to maintain constant pressure on the electrodes throughout the 
test, the palms must be consciously maintained flat and steady 
for optimal test quality. The mean hands and feet ESCs observed 
among PDT2 were lower than those in HV, most likely second-
ary to diabetic peripheral neuropathy in some of the patients. 
However, the coefficients of repeatability and reproducibility 
remained acceptable.
Statistical tests used to compare measurements were issued 
from ISO 5725-2 standard “Accuracy (trueness and precision) of 
measurement methods and results – Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard 
measurement method” as recommended by Food and Drug 
Administration and completed with Bland–Altman analysis 
and ICC that are more frequently reported in publications. All 
analyses demonstrated repeatability and reproducibility values 
that are quite acceptable and comparable to variations observed 
with other tests used to assess peripheral neuropathies.
Several factors may explain the good repeatability and repro-
ducibility of the ESC measurement:
 (a) There is a direct and calibrated electrical stimulation of the 
sweat gland, contrary to methods that depend on a pharma-
cological stimulus that is potentially more variable (28).
 (b) The stratum corneum is electrically insulating against 
DC voltages under 10  V and only the appendageal 
FIGURe 2 | Mean values and SD observed for the six measurements of each subject [(a) healthy population and (B) patients with type 2 diabetes].
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pathways of the eccrine sweat glands are conductive; 
thus, ESC does not depend on the thickness of the stra-
tum corneum (23).
 (c) The electrode is firmly applied to the skin, effectively plug-
ging the pores of the glands and blocking any physiological 
sweat flow, thus minimizing a possible dependence of the 
test on conditions that could increase this flow, such as high 
temperature or exercise.
 (d) The stainless-steel electrodes are sensitive to chlorides, a key 
factor for the electrochemical reaction (29).
 (e) The active measurement is conducted with the same constant 
polarizations at voltage levels that are at least 10 times higher 
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than physiological ones; hence, ESC does not depend on the 
sweat composition or conductivity.
 (f) ESC is computed by the slope of the curve (resulting cur-
rent – applied voltage) and, therefore, is not affected by any 
electrochemical over potential of the electrode (30).
 (g) The internal electronic circuit of the technology can measure 
the voltages precisely, with an accurate analog-to-digital 
converter having a resolution of 10 bits.
Results observed in this study can be compared to other meth-
ods used for assessment of small or large fiber structure or function. 
The variability for skin biopsy was investigated by Smith et al. on 
IENFD measurements from different sections and punches made 
by two different observers (inter-observer variability) using a total 
of 48 punch biopsies obtained from 22 patients. Intra-observer vari-
ability (two measures by the same observer) was also determined 
for 50% of the sections and punches. Mean (SD) inter-observer 
variability was 9.6 ± 9.4% for each biopsy site and 10.2 ± 11.9% for 
individual sections. Mean intra-observer variability was 9.6 ± 8.9% 
for biopsies, and 8.8 ± 9.0% for sections (31).
Repeatability of QSART and QST was assessed on 23 patients: 
19 patients underwent repeat QST testing, and 13 patients 
underwent repeat QSART testing. QST (cold detection threshold 
ICC was 0.80, vibration detection threshold ICC was 0.75) was 
more reproducible than QSART (ICC foot 0.52). Repeatability of 
QSART was similar for the forearm, proximal leg and foot sites 
(0.52–0.63). The distal leg site was the least repeatable, with an 
ICC of 0.42. The rather poor repeatability of QSART could be 
explained by the fact that the authors used equipment similar 
but not identical to the original device designed at the Mayo 
Clinic (32). Sletten et al. established that the current delivered for 
acetylcholine iontophoresis i.e., the stimulus for the axon-reflex 
sweat production depends on the characteristics of the stimula-
tor, return electrodes, and the skin resistance of the participant 
and is a critical issue for test performance (28).
Smith et al. determined the reproducibility of corneal confo-
cal microscopy, a method to assess small fiber neuropathy in the 
cornea of 11 normal subjects using the same device (a Heidelberg 
Retinal Tomography III microscope) in five standardized loca-
tions. Nerve fiber length showed high reproducibility, with a 
relative inter-trial variability (RIV) of 5.02 ±  2.8% and ICC of 
0.92 when five locations were averaged, and 6.92 ± 5.3% and ICC 
of 0.84 when four were averaged. Tortuosity coefficient was less 
reproducible, with a mean RIV of 13.6 ± 11% and ICC of 0.57 
(p < 0.030) when five images were averaged (33).
Papanas et  al. investigated reproducibility of Neuropad and 
showed that in patients with sudomotor dysfunction, intra-observer 
CV ranged between 4.2 and 5.1% (right foot) and between 4.1 and 
5% (left foot), while inter-observer CV ranged between 4.3 and 
4.9% (for either right or left foot). In patients without sudomotor 
dysfunction, intra-observer CV ranged between 4.1 and 4.8% (right 
foot) and between 4.1 and 4.7% (left foot), while inter-observer 
CV ranged between 4.3 and 4.7% (right foot) and between 4.2 and 
4.5% (left foot) (34). No formal reproducibility of QDIRT or DST 
could be identified in the English language literature.
Taksande et  al. computed the inter-observer reproducibility 
between two examiners for the diagnosis of peripheral neuropathy 
in patients with type 2 diabetes using a clinical examination, includ-
ing vibration perception, 10-g monofilament touch sensation, and 
ankle reflexes (35). Measures of reproducibility used were percent 
agreement and kappa statistic (percent agreement beyond chance). 
For impaired vibration, impaired sensation and absence of reflex, 
percent agreements were 83, 82, and 77, respectively, while kap-
pas were 0.35 (0.11–0.60), 0.53 (0.35–0.72), and 0.45 (0.27–0.64), 
signaling moderate-to-poor reproducibility. Similarly, Maser et al. 
evaluated inter-observer variation in a neurological examination 
to assess small and large fiber function on three separate occa-
sions. Among five non-diabetic subjects, the mean coefficients of 
variation (CV) of log10-transformed variables were for vibration 
testing: finger 20% and great toe 16%, and for thermal testing: 
finger 34% and great toe 24%; among five diabetic subjects, the 
mean CV were for vibration testing: finger 8% and great toe 8%, 
and for thermal test: finger 29% and great toe 26% (36).
There are some limitations to this analysis and ESC measure-
ments: (i) sudomotor function is principally controlled by cho-
linergic activity; the effect of drugs with anti-cholinergic activity 
on the device accuracy has not been investigated; (ii) the diabetic 
subjects in this report are not fully characterized according to 
AAN polyneuropathy criteria (37); it is, therefore, not possible to 
ascertain whether these accuracy measures apply to all degrees 
of peripheral neuropathy; (iii) almost all individuals can safely 
undergo ESC testing; however, measurements cannot be obtained 
on individuals with an amputated hand or foot.
CoNCLUSIoN
This study establishes that repeatability and reproducibility of 
ESC measurements appear to be respectable in HVs and patients 
with type 2 diabetes. Variation is comparable to or lower than 
methods commonly used in the assessment of small or large 
fiber neuropathy especially those that are operator- or patient 
dependent. Based on these results and the ease, speed, and non-
invasiveness of testing, the ESC method could be considered for 
the follow-up of patients and as an endpoint in multi-center trials.
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